P. Pagella

发表

Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives

Emanuela Licandro, Mario Brufani, Maria Alessandra Alisi, 1995 .

Synthesis and Structure‐Activity Relationships of New Acetylcholinesterase Inhibitors: Morpholinoalkylcarbamoyloxyeseroline Derivatives (III).

E. Licandro, M. Alisi, M. Brufani, 1996 .

New analogs of physostigmine: alternative drugs for Alzheimer's disease?

M. Pomponi, A. Oliverio, C. Castellano, 1988, Life sciences.

A long-lasting cholinesterase inhibitor affecting neural and behavioral processes

M. Pomponi, A. Oliverio, C. Castellano, 1987, Pharmacology Biochemistry and Behavior.

Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.

M. Donati, M. Abbadini, P. Pagella, 1987, Haemostasis.

6-Aminoquinolones: a new class of quinolone antibacterials?

G. Cruciani, S. Clementi, O. Tabarrini, 1995, Journal of medicinal chemistry.

7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-CoA reductase inhibitors.

O. Tabarrini, V. Cecchetti, A. Fravolini, 1994, Bioorganic & medicinal chemistry.

Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.

G. Segre, V. Cecchetti, A. Fravolini, 1987, Journal of medicinal chemistry.

1,4-Benzothiazine-2-carboxylic acid 1-oxides as analogues of antibacterial quinolones †

O. Tabarrini, V. Cecchetti, A. Fravolini, 1992 .

Synthesis of some thiophosphate analogues (C-S-P) of phosphatidylinositol

S. Maiorana, M. Alisi, M. Brufani, 1992 .

Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates

S. Iversen, S. Tye, N. Rupniak, 1992, Journal of the Neurological Sciences.

Heptylphysostigmine — Novel Acetylcholinesterase Inhibitor: Biochemical and Behavioral Pharmacology

G. Dawson, S. Iversen, L. Iversen, 1991 .

The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents

G. Dawson, S. Iversen, G. Bentley, 1991, Pharmacology Biochemistry and Behavior.

Pharmacological and toxicological studies on an iron succinyl-protein complex (ITF282) for oral treatment of iron deficiency anemia.

P. Pagella, G. Donà, O. Bellavite, 1984, Arzneimittel-Forschung.

The analytical profile of rufloxacin, a new fluoroquinolone, by reversed-phase high-performance liquid chromatography.

P. Melchiorre, P. Pagella, E. Bossù, 1990, Journal of pharmaceutical and biomedical analysis.

Synthesis of some carbamates of myo-inositol.

M. Brufani, L. Filocamo, G. Gostoli, 1992, Carbohydrate research.

Effects of MF‐268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex

E. Giacobini, M. Brufani, P. Pagella, 1996, Journal of neuroscience research.

In Vitro Activity of MF 5137, a New Potent 6-Aminoquinolone

O. Tabarrini, V. Cecchetti, A. Fravolini, 2012, Drugs.

Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection.

D. Radice, A. Mosca, L. Zecca, 1993, Journal of chromatography.

Drug modulation of superoxide anion production from human neutrophils.

R. Fantozzi, S. Brunelleschi, P. Pagella, 1985, International journal of tissue reactions.

Dualism in the α-adrenoceptor blocking action of dihydroergocristine

A. Lucchelli, P. Pagella, F. Zonta, 1981 .